About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5605023
Allelic
Composition
Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe/?
Krt19tm1(cre/ERT)Ggu/?
Genetic
Background
B6.Cg-Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe Krt19tm1(cre/ERT)Ggu
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe mutation (0 available); any Gt(ROSA)26Sor mutation (1098 available)
Krt19tm1(cre/ERT)Ggu mutation (1 available); any Krt19 mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• 13 days after tamoxifen injection, a greater proportion of insulin-immunostaining duct cells are observed in pancreas sections from 6-9 week old mice bearing both the conditional Neurog3 knock-in and a pancreatic duct-specific cre recombinase/estrogen receptor fusion knock-in allele than in sections from control mice with only the conditional allele (highly significant at p = 0.0042 (<= 0.01) by Student's unpaired t test).


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/18/2025
MGI 6.24
The Jackson Laboratory